Our experiments showed that NCL-1 treatment also reduced HIF1A in the central regions of the xenograft tumors, where blood vessels were also lost and tumor cell proliferation was suppressed in addition to apoptosis or differentiation to ganglion cells being induced. The gene discussed is CAPN3; the disease is neoplasm.